经导管CT肝动脉造影与常规CT引导经皮微波消融治疗小肝癌的比较
本研究回顾性比较了经导管CT肝动脉造影引导(AA)与常规CT引导(CA)经皮微波消融治疗小于3cm肝细胞癌的安全性和疗效。
要点
- AA组3个月完全缓解率显著高于CA组(100% vs 79.6%,P=0.0042)。
- AA组2年无进展生存率更高(95.8% vs 68.5%,log-rank P=0.0099)。
- 两组总生存率相似(log-rank P=0.583),安全性相当。
局限性
- 回顾性研究设计。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the safety and efficacy of transcatheter CT hepatic arteriography (angio-CT)-guided percutaneous microwave ablation (AA) for small hepatocellular carcinoma tumors and compare its outcomes with those of conventional CT-guided microwave ablation (CA). Materials and Methods The authors performed a retrospective review of patients with hepatocellular carcinoma tumors less than 3 cm in size treated with AA and CA from June 2019 to August 2024 at a single institution. Hepatic arteriography was performed after transarterial catheterization in an angio-CT hybrid suite. CA was performed with or without US. The authors evaluated the target-lesion radiologic response according to modified Response Evaluation Criteria in Solid Tumors criteria at follow-up contrast-enhanced CT or MRI. Target-lesion progression-free survival (PFS) and overall survival were calculated using the Kaplan-Meier method. Cox regression hazard models were used to identify variables associated with PFS. Adverse events were retrospectively reviewed. Results A total of 70 patients and 85 tumors were included in this study (mean age, 63.2 years ± 9.5 [SD]; 49 male patients). Thirty-six tumors (27 patients) were treated with AA. Forty-nine tumors (43 patients) were treated with CA. The 3-month complete response rate (100% vs 79.6%; P = .0042) and the 2-year PFS rate (95.8% vs 68.5%; log-rank P = .0099) were higher for the AA group than the CA group. Overall survival was similar between the groups (log-rank P = .583). In the multivariable analysis, AA but not CA was independently associated with increased PFS (P = .009). One patient from the CA group developed hemorrhagic shock after ablation. No other severe adverse events or grade 3 or above hepatic toxicities occurred. Conclusion For hepatocellular carcinoma tumors less than 3 cm in size, AA resulted in higher initial response and PFS rates than CA with comparable safety profile. Keywords: Angio-CT, Hepatocellular Carcinoma, Microwave Ablation Supplemental material is available for this article. © RSNA, 2026.
引用
- Yu Q, Ahmed Z, Lim W, et al. Transcatheter CT Hepatic Arteriography versus Conventional CT Guidance for Percutaneous Microwave Ablation of Small Hepatocellular Carcinoma Tumors. Radiol Imaging Cancer. 2026. PMID: 42171489. doi:10.1148/rycan.250106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。